Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer.
Journal: The New England journal of medicine
Published: January 15, 2025
PTEN inactivating mutations are associated with hormone receptor loss during breast cancer recurrence.
Journal: Breast cancer research and treatment
Published: October 22, 2024
Trends in breast cancer-specific death by clinical stage at diagnoses between 2000 and 2017.
Journal: Journal of the National Cancer Institute
Published: June 04, 2024
Tucatinib vs Placebo, Both in Combination With Trastuzumab and Capecitabine, for Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer in Patients With Brain Metastases: Updated Exploratory Analysis of the HER2CLIMB Randomized Clinical Trial.
Journal: JAMA oncology
Published: December 01, 2022
Adjuvant T-DM1 versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for HER2-positive breast cancer: subgroup analyses from KATHERINE.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: November 02, 2020
Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 30, 2020
Changing frameworks in treatment sequencing of triple-negative and HER2-positive, early-stage breast cancers.
Journal: The Lancet. Oncology
Published: January 07, 2019
Acquired Resistance to HER2-Targeted Therapies Creates Vulnerability to ATP Synthase Inhibition.
Journal: Cancer research
Published: December 19, 2018
The impact of communication style on patient satisfaction.
Journal: Breast cancer research and treatment
Published: December 17, 2018
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer.
Journal: The New England journal of medicine
Published: December 06, 2018
Bidirectional Text Messaging to Monitor Endocrine Therapy Adherence and Patient-Reported Outcomes in Breast Cancer.
Journal: JCO clinical cancer informatics
Published: November 01, 2017
Last Updated: 09/26/2026